Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00420628 · ClinicalTrials.gov registry record · Phase 4
Pediatric Zylet Safety and Efficacy Study
A Phase 4 study of Chalazion and Hordeolum, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- Phase 4
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT00420628: Completed Phase 4 study of Chalazion and Hordeolum, sponsored by Bausch & Lomb Incorporated.
NCT00420628 is a Phase 4 study of Chalazion and Hordeolum that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 108 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00420628, a Phase 4 study of Chalazion and Hordeolum, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
A multicenter study to evaluate the safety and efficacy of Zylet compared to vehicle in children aged 0-6 for the management of lid inflammation (chalazion/hordeolum)
Primary Outcome
Study eye - Safety Population, At all visits 1,2,3
Interventions
- DRUG vehicle
- DRUG loteprednol etabonate/tobramycin opthalmic suspension
Study Locations (1)
Pennsylvania
- Pediatric Ophthalmology of Erie - Erie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-06 |
| Phase | Phase 4 |
What the finished NCT00420628 record still lists
NCT00420628 is an interventional study that assigns participants to a tested intervention. The registered 108 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (79% lower).
The record links to 2 conditions, with Chalazion appearing as the primary indexed condition, and to 2 interventions - of which vehicle is the first listed.
NCT00420628 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00420628 about?
NCT00420628 is a clinical study titled "Pediatric Zylet Safety and Efficacy Study". A multicenter study to evaluate the safety and efficacy of Zylet compared to vehicle in children aged 0-6 for the management of lid inflammation (chalazion/hordeolum)
What is the current status of trial NCT00420628?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 108 participants. The study started on 2006-11. Estimated completion is 2009-06.
What conditions does trial NCT00420628 study?
This clinical trial studies the following conditions: Chalazion, Hordeolum.
What interventions are being tested in trial NCT00420628?
The interventions under investigation include: vehicle (DRUG), loteprednol etabonate/tobramycin opthalmic suspension (DRUG).
Who is sponsoring clinical trial NCT00420628?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00420628 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chalazion
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00420628's enrollment target sits among peer trials
108 740th of 2000 higher than 1,256 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02703207 · 108 participants · NA
Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD
- NCT02744677 · 108 participants · NA
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve Dysfunction
- NCT02781883 · 108 participants · Phase 2
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
- NCT03848663 · 108 participants · NA
Visual Remapping to Aid Reading With Field Loss
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia